Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Asthma
NCT02605824Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Mar 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acetylcysteine in asthma, sponsored by University of California, San Francisco. Started Mar 2016; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02605824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02605824.